Dose: 2,330 mcg (2.33 mg) total blend daily, providing approximately 1.7 mg GHK-Cu, 0.33 mg TB-500, and 0.33 mg BPC-157 per injection
V., Sevan'kaeva, L
, stable in human gastric juice more than 24 hours, and use without carrier (otherwise, peptide + carrier(s) -complex bears considerable methodological/activity dilemmas), prominent antiulcer effect, and a safe application in inflammatory bowel disease patients with improved wound/intestinal anastomosis healing, adhesion prevention, collagen deposition, and anastomotic strength, along with prominent effect in cuprizone rats ( i.e
Limitations stated clinical research in humans is described as "limited" and unapproved status is named clearly
UCHL5 positively regulates Hedgehog signaling by removing ubiquitination of Smoothened, Frizzled class receptor (SMO) protein in cancer cells (Zhou et al., 2018)